Literature DB >> 20645986

Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Merry L Lindsey1, Rogelio Zamilpa.   

Abstract

Following a myocardial infarction (MI), the homeostatic balance between matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) is disrupted as part of the left ventricle (LV) response to injury. The full complement of responses to MI has been termed LV remodeling and includes changes in LV size, shape and function. The following events encompass the LV response to MI: (1) inflammation and LV wall thinning and dilation, (2) infarct expansion and necrotic myocyte resorption, (3) accumulation of fibroblasts and scar formation, and (4) endothelial cell activation and neovascularization. In this review, we will summarize MMP and TIMP roles during these events, focusing on the spatiotemporal localization and MMP and TIMP effects on cellular and tissue-level responses. We will review MMP and TIMP structure and function, and discuss specific MMP roles during both the acute and chronic phases post-MI, which may provide insight into novel therapeutic targets to limit adverse remodeling in the MI setting.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20645986      PMCID: PMC2972388          DOI: 10.1111/j.1755-5922.2010.00207.x

Source DB:  PubMed          Journal:  Cardiovasc Ther        ISSN: 1755-5914            Impact factor:   3.023


  101 in total

1.  Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3.

Authors:  Simon A Fry; Philippe E Van den Steen; Louise Royle; Mark R Wormald; Anthony J Leathem; Ghislain Opdenakker; James M McDonnell; Raymond A Dwek; Pauline M Rudd
Journal:  Biochemistry       Date:  2006-12-06       Impact factor: 3.162

2.  Effect of species differences on stromelysin-1 (MMP-3) inhibitor potency. An explanation of inhibitor selectivity using homology modeling and chimeric proteins.

Authors:  L L Johnson; D A Bornemeier; J A Janowicz; J Chen; A G Pavlovsky; D F Ortwine
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

3.  Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.

Authors:  S Heymans; A Luttun; D Nuyens; G Theilmeier; E Creemers; L Moons; G D Dyspersin; J P Cleutjens; M Shipley; A Angellilo; M Levi; O Nübe; A Baker; E Keshet; F Lupu; J M Herbert; J F Smits; S D Shapiro; M Baes; M Borgers; D Collen; M J Daemen; P Carmeliet
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

4.  Digestion of C1q collagen-like domain with MMPs-1,-2,-3, and -9 further defines the sequence involved in the stimulation of neutrophil superoxide production.

Authors:  S Ruiz; A H Henschen-Edman; H Nagase; A J Tenner
Journal:  J Leukoc Biol       Date:  1999-09       Impact factor: 4.962

5.  Myocardial infarction and remodeling in mice: effect of reperfusion.

Authors:  L H Michael; C M Ballantyne; J P Zachariah; K E Gould; J S Pocius; G E Taffet; C J Hartley; T T Pham; S L Daniel; E Funk; M L Entman
Journal:  Am J Physiol       Date:  1999-08

6.  Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments.

Authors:  A Bini; D Wu; J Schnuer; B J Kudryk
Journal:  Biochemistry       Date:  1999-10-19       Impact factor: 3.162

7.  Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion.

Authors:  C C Danielsen; H Wiggers; H R Andersen
Journal:  J Mol Cell Cardiol       Date:  1998-07       Impact factor: 5.000

8.  Differential expression of tissue inhibitors of metalloproteinases in the failing human heart.

Authors:  Y Y Li; A M Feldman; Y Sun; C F McTiernan
Journal:  Circulation       Date:  1998-10-27       Impact factor: 29.690

9.  Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.

Authors:  U Schönbeck; F Mach; P Libby
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

10.  Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction.

Authors:  Rika Kawakami; Yoshihiko Saito; Ichiro Kishimoto; Masaki Harada; Koichiro Kuwahara; Nobuki Takahashi; Yasuaki Nakagawa; Michio Nakanishi; Keiji Tanimoto; Satoru Usami; Shinji Yasuno; Hideyuki Kinoshita; Hideki Chusho; Naohisa Tamura; Yoshihiro Ogawa; Kazuwa Nakao
Journal:  Circulation       Date:  2004-11-15       Impact factor: 29.690

View more
  61 in total

Review 1.  Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.

Authors:  Merry L Lindsey; Rugmani Padmanabhan Iyer; Mira Jung; Kristine Y DeLeon-Pennell; Yonggang Ma
Journal:  J Mol Cell Cardiol       Date:  2015-12-23       Impact factor: 5.000

2.  Cardiac wound healing post-myocardial infarction: a novel method to target extracellular matrix remodeling in the left ventricle.

Authors:  Rogelio Zamilpa; Jianhua Zhang; Ying Ann Chiao; Lisandra E de Castro Brás; Ganesh V Halade; Yonggang Ma; Sander O Hacker; Merry L Lindsey
Journal:  Methods Mol Biol       Date:  2013

3.  Potential clinical implications of recent matrix metalloproteinase inhibitor design strategies.

Authors:  Sabrina Amar; Gregg B Fields
Journal:  Expert Rev Proteomics       Date:  2015-07-15       Impact factor: 3.940

Review 4.  Myocardial matrix metalloproteinase-2: inside out and upside down.

Authors:  Ashley DeCoux; Merry L Lindsey; Francisco Villarreal; Ricardo A Garcia; Richard Schulz
Journal:  J Mol Cell Cardiol       Date:  2014-09-28       Impact factor: 5.000

5.  Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function.

Authors:  Shayne C Barlow; Heather Doviak; Julia Jacobs; Lisa A Freeburg; Paige E Perreault; Kia N Zellars; Karen Moreau; Camila F Villacreses; Stephen Smith; Aarif Y Khakoo; TaeWeon Lee; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-28       Impact factor: 4.733

6.  Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Yuanjian Chen; Victoria S Li; Weixin Meng; Yao Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

Review 7.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

8.  Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-Myocardial Infarction Remodeling.

Authors:  David C Lobb; Heather Doviak; Gregory L Brower; Eva Romito; Jason W O'Neill; Stephen Smith; James A Shuman; Parker D Freels; Kia N Zellars; Lisa A Freeburg; Aarif Y Khakoo; TaeWeon Lee; Francis G Spinale
Journal:  J Pharmacol Exp Ther       Date:  2020-09-21       Impact factor: 4.030

Review 9.  Using proteomics to uncover extracellular matrix interactions during cardiac remodeling.

Authors:  Nicolle L Patterson; Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Yaojun Li; Thomas G Andrews; Gregory J Aune; Richard A Lange; Merry L Lindsey
Journal:  Proteomics Clin Appl       Date:  2013-07-08       Impact factor: 3.494

10.  Vascular endothelial growth factor-C: its unrevealed role in fibrogenesis.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Weixin Meng; Chang Liu; Yuanjian Chen; Yao Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-24       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.